News and Events
Release News
PharmaPendium 2013.3 Release
The content release includes the following updates:
FDA Approval Packages:
• 15 new drugs:
Ado-Trastuzumab Emtansine
Alogliptin Benzoate
Alogliptin Benzoate; Metformin Hydrochloride
Alogliptin Benzoate; Pioglitazone Hydrochloride
Bedaquiline Fumarate
Crofelemer
Glycerol Phenylbutyrate
Hydrocodone Bitartrate; Chlorpheniramine Maleate
Lomitapide Mesylate
Loxapine
Mipomersen Sodium
Pomalidomide
Raxibacumab
Sodium, Potassium, Magnesium Sulfates; Sodium, Potassium Chlorides; Sodium Bicarbonate
Teduglutide Recombinant
• 1,029 new FDA Approval Documents
• 20,934 new pages of FDA Approval Documents
Extracted PK data observations:
• 10,486 new extracted PK data lines
Extracted Safety data observations:
• 11,022 new extracted safety data lines
Metabolizing Enzymes Database:
• 164,265 new safety records
Published Toxicity Database:
• 367 new safety records
The new totals for PharmaPendium are:
• 1,729,917 pages of FDA Approval documents (Including FDA Classic Collection)
• 76,202 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,145 drugs with data in PharmaPendium
• 1,239,405 extracted safety data lines
• 1,331,058 extracted PK data lines
• 164,265 extracted ME data lines
• 5,259,028 AERS (post-marketing) reports
• 6,002 documents / 107,300 pages of EMA Approval documents
• 11,842 documents / 491,869 pages of FDA Advisory Committee Meeting documents
• 10,906 documents / 308,015 pages of FDA Classic Collection
Year-To-Date EMA and FDA approval documents statistics for 2013
(PP 2013.1 + PP 2013.2 + 2013.3):
• 4,626 new documents
• 90,974 new pages
• 37,692 new extracted PK data observations
• 58,529 new extracted safety data observations
• 164,265 new extracted ME data observations
• 26 new drugs
